HOME >> BIOLOGY >> NEWS
Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market

Indianapolis/Brussels: Four months after the world's first vaccine made in plant cells has received regulatory approval in the US, Dow AgroSciences is organising a Science Conference in Brussels on 7 June 2006 in order to share this knowledge with European researchers, scientists, decision-makers and industry representatives.

The pioneering vaccine developed by Dow AgroSciences works against the Newcastle disease virus (NDV) in poultry. The latest technology could be applied quite quickly to other diseases - with avian flu a prime target. This approval represents an innovative milestone for the company and the industry.

The Dow AgroSciences Concert Plant-Cell-Produced System represents a new category of plant-made vaccines. This leading edge technology utilises plant cells instead of whole plants in a secure, bio-contained environment to produce vaccines. Because of this bio-contained production system, concerns and challenges associated with making vaccines in whole plants or food crops are eliminated. The Concert Plant-Cell-Produced System uses only the necessary parts of the disease causing agent to stimulate immunity in a manufacturing process that is totally free of animal components: "Being the first company to ever register a plant-made vaccine is another example of Dow AgroSciences' cutting edge approach to bringing highly novel and differentiated solutions to the market," said Jerome Peribere, Dow AgroSciences' president and CEO.

The conference on 7 June, entitled "Innovations in Biosciences for Animal and Human Health" will highlight major bioscience developments and scientific solutions that could prevent diseases and reduce animal and human health risks in Europe. Dow AgroSciences President and Chief Executive Officer Mr. Jerome A. Peribere will deliver a welcome address. Dow AgroSciences's R&D capability will be presented by Mr. Antonio Galindez, (Dow AgroSciences Vice President, Europe, Latin America, Pacific) and Dr. Dan Kit
'"/>

Contact: Marta Czerniawska
marta@isc-europe.com
032-401-6147
ISC
31-May-2006


Page: 1 2

Related biology news :

1. Researchers use new approach to predict protein function
2. New approach to pulmonary hypertension shows promise
3. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
4. New approaches to endometriosis treatment -- mouse experiments point the way
5. Reconstructing the biology of extinct species: A new approach
6. Screening approach leads to discovery of gene linked to breast cancer
7. In new statistical approach, data decide model
8. Bigelow Laboratory Scientists develop new approach to study marine microbes
9. New understanding of schizophrenia could lead to new treatment approaches
10. Cheaper, better disease treatments expected from faster approach to developing antibodies
11. New imaging approach promises insights into multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... , ... August 19, 2020 , ... ... premier conference and expo uniting life science, data science, informatics and IT leaders ... , “In this period of uncertainty and change, Bio-IT takes the leadership role ...
(Date:8/7/2020)... SAN FRANCISCO (PRWEB) , ... August 06, 2020 ... ... the life sciences industry, is pleased to announce that Eric Chen and Jessica ... Vice President of Product Management & Strategy, respectively. , Eric Chen heads development ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense ... to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
(Date:7/10/2020)... ... 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will ... SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at the ...
Breaking Biology Technology:
Cached News: